Abeona Therapeutics logo

Abeona Therapeutics

ABEO | NASDAQ
Chart Builder DCF Calculator
$2.60
+$0.18 (+7.44%)
At close: Nov 16, 2026, 4:00 PM ET
$2.62
+$0.02 (+0.77%)
After-hours: Nov 16, 2026, 7:30 PM ET
+7.44%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
51
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #256/1021 (Top 25%)

Key Statistics

Market Data

Market Cap $148.58M
1D Range
2.36 2.62
52W Range
2.29 7.46

Valuation (TTM)

PE -2.39
PB 1.18
EV/EBITDA -0.54

Valuation (NTM)

Forward PE 372.72
Forward PEG 0.01
Price Target $17.00
Loading financial charts...

Profile

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its l...

Sector Healthcare
Industry Biotechnology
Employees 226
IPO Date Sep 19, 1980
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 9, 2026
EPS
-$0.08
Beat +54.10%
REV
$13.49M
Miss -8.96%
Next Earnings
Mar 16, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$17.00
Upside
+553.85%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.